Carbone, Michele
Amelio, Ivano
Affar, El Bachir
Brugarolas, James
Cannon-Albright, Lisa A
Cantley, Lewis C.
Cavenee, Webster K.
Chen, Zhijian
Croce, Carlo M.
Andrea, Alan D’ http://orcid.org/0000-0001-6168-6294
Gandara, David
Giorgi, Carlotta
Jia, Wei http://orcid.org/0000-0002-3739-8994
Lan, Qing
Mak, Tak Wah
Manley, James L.
Mikoshiba, Katsuhiko
Onuchic, Jose N
Pass, Harvey I.
Pinton, Paolo http://orcid.org/0000-0001-7108-6508
Prives, Carol
Rothman, Nathaniel
Sebti, Said M. http://orcid.org/0000-0001-5163-1038
Turkson, James
Wu, Xifeng
Yang, Haining
Yu, Herbert
Melino, Gerry
Article History
Received: 14 July 2018
Accepted: 6 August 2018
First Online: 15 October 2018
Compliance with ethical standards
:
: M.C. has pending patent applications on BAP1; H.I.P., has patents pending for use of fibulin-3 for diagnosis of mesothelioma; M.C., H.Y and H.I.P. have patents pending for use of HMGB1 for diagnosis of mesothelioma; M.C. and H.Y. have patents pending for use of HMGB1 and its isoforms for diagnosis of mesothelioma; M.C. provides cost-free consultation for MM expertise and diagnosis to patients and colleagues and paid medical-legal expertise. The remaining authors declare that they have no conflict of interest.